🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Paul A. VanderLaan

Beth Israel Deaconess Medical Center

ORCID: 0000-0002-7234-5652

Also affiliated with Harvard University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.757Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A Real-World Study of Patient Characteristics and Clinical Outcomes in EGFR Mutated Lung Cancer Treated with First-Line Osimertinib: Expanding the FLAURA Trial Results into Routine Clinical Practice

Cancers(2024)10.3390/cancers16061079
Top 27%
0.757DataRank
Top 27%17 citations

Andrew J. Piper‐Vallillo, Page Widick, Emmeline C. Academia, Meghan Shea, Deepa Rangachari +4 more

Papers

Driven by 17 papers — median percentile 73. Top paper: “A Real-World Study of Patient Characteristics and Clinical Outcomes in EGFR Mutated Lung Cancer Treated with First-Line Osimertinib: Expanding the FLAURA Trial Results into Routine Clinical Practice”.

A Real-World Study of Patient Characteristics and Clinical Outcomes in EGFR Mutated Lung Cancer Treated with First-Line Osimertinib: Expanding the FLAURA Trial Results into Routine Clinical Practice

Cancers(2024)10.3390/cancers16061079
Top 27%
0.757DataRank
Top 27%17 citations

Andrew J. Piper‐Vallillo, Page Widick, Emmeline C. Academia, Meghan Shea, Deepa Rangachari +4 more

Small cell transformation of non-small cell lung cancer on immune checkpoint inhibitors: uncommon or under-recognized?

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000697
N/A
0DataRank · unranked
48 citations

Andreas Varkaris, Hollis Viray, Paul A. VanderLaan, Deepa Rangachari, Daniel B. Costa +1 more

Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non–small-cell Lung Cancer

Clinical Lung Cancer(2020)10.1016/j.cllc.2020.05.028
N/A
0DataRank · unranked
22 citations

Anushi Bulumulle, Heather Brody, Ritu R. Gill, Shravanti Macherla, Aleksandra Qilleri +10 more

CD1d Selectively Down Regulates the Expression of the Oxidized Phospholipid-Specific E06 IgM Natural Antibody in Ldlr−/− Mice

Antibodies(2020)10.3390/antib9030030
N/A
0DataRank · unranked
4 citations

Paul A. VanderLaan, Xuchu Que, Ayelet Gonen, Paulette A. Krishack, Christoph J. Binder +4 more

Diagnostic Accuracy of Endobronchial Optical Coherence Tomography for the Microscopic Diagnosis of Usual Interstitial Pneumonia

American Journal of Respiratory and Critical Care Medicine(2021)10.1164/rccm.202104-0847oc
N/A
0DataRank · unranked
64 citations

Rebecca A. Raphaely, Ashok Muniappan, Angela Shih, Benjamin W. Roop, Amita Sharma +24 more

All in for patient safety: a team approach to quality improvement in our laboratories

Journal of the American Society of Cytopathology(2021)10.1016/j.jasc.2021.12.001
N/A
0DataRank · unranked
6 citations

Yael Heher, Adam C. Seegmiller, Paul A. VanderLaan, Michiya Nishino, Vivian Weiß

COVID‐19 pandemic impact on cytopathology practice in the post‐lockdown period: An international, multicenter study

Cancer Cytopathology(2022)10.1002/cncy.22547
N/A
0DataRank · unranked
22 citations

Pasquale Pisapia, Filippo Dello Iacovo, Eduardo Alcaraz‐Mateos, Greta Alì, Syed Z. Ali +62 more

Reply to Kalverda et al. : Endobronchial Optical Coherence Tomography: Shining New Light on Diagnosing Usual Interstitial Pneumonitis?

American Journal of Respiratory and Critical Care Medicine(2022)10.1164/rccm.202112-2737le
N/A
0DataRank · unranked
3 citations

Rebecca A. Raphaely, Ashok Muniappan, Angela Shih, Benjamin W. Roop, Amita Sharma +24 more

EGFR exon 20 insertion mutations and ERBB2 mutations in lung cancer: a narrative review on approved targeted therapies from oral kinase inhibitors to antibody-drug conjugates

Translational Lung Cancer Research(2023)10.21037/tlcr-23-98
N/A
0DataRank · unranked
33 citations

Emmeline C. Academia, Hollis Viray, Deepa Rangachari, Susumu Kobayashi, Paul A. VanderLaan +2 more

The Impact of On-Target Resistance Mediated by EGFR-T790M or EGFR-C797S on EGFR Exon 20 Insertion Mutation Active Tyrosine Kinase Inhibitors

JTO Clinical and Research Reports(2023)10.1016/j.jtocrr.2023.100614
N/A
0DataRank · unranked
11 citations

William O. Shaffer, Hollis Viray, Deepa Rangachari, Paul A. VanderLaan, Susumu Kobayashi +2 more

EGFR exon 19 insertion EGFR-K745_E746insIPVAIK and others with rare XPVAIK amino-acid insertions: Preclinical and clinical characterization of the favorable therapeutic window to all classes of approved EGFR kinase inhibitors

Lung Cancer(2023)10.1016/j.lungcan.2023.107250
N/A
0DataRank · unranked
6 citations

Ikei S. Kobayashi, Daniel Sentana‐Lledo, Shriram K. Sundararaman, Meghan Lee, Deepa Rangachari +4 more

ALK Deletion Exons 2 to 19: Case Report of a Rare ALK Inhibitor–Responsive Lung Cancer Driver Oncogene

JTO Clinical and Research Reports(2023)10.1016/j.jtocrr.2023.100489
N/A
0DataRank · unranked
0 citations

Emmeline C. Academia, Soravis A. Osataphan, Deepa Rangachari, Sheida Sharifi, Paul A. VanderLaan +2 more

Comparative genomic and immunopathologic analysis of lung adenocarcinomas with and without cytology‐proven malignant pleural effusions

Cancer Cytopathology(2024)10.1002/cncy.22900
N/A
0DataRank · unranked
2 citations

Adnan Majid, Daniel B. Costa, Paul A. VanderLaan, Cristiana M. Pineda

Rapid examination of lung tissues by nonlinear microscopy

American Journal of Clinical Pathology(2024)10.1093/ajcp/aqae046
N/A
0DataRank · unranked
3 citations

Timothy D. Weber, James G. Fujimoto, Seymour Rosen, Paul A. VanderLaan, Yue Sun

Endobronchial ultrasound-guided sampling: diagnostic yield of needle biopsy and cryobiopsy in addition to needle aspiration

Annals of the American Thoracic Society(2025)10.1513/annalsats.202502-223oc
N/A
0DataRank · unranked
6 citations

Hamad Nasim, Jacqueline Chen, Annika Bharwani, Juan Sebastián Lara, Raymond Parrish +6 more

EGFR-A763_Y764insFQEA Is a Unique Exon 20 Insertion Mutation That Displays Sensitivity to Approved and In-Development Lung Cancer EGFR Tyrosine Kinase Inhibitors

JTO Clinical and Research Reports(2020)10.1016/j.jtocrr.2020.100051
N/A
0DataRank · unranked
81 citations

Carol Gergis, Hollis Viray, Andreas Varkaris, Masanori Fujii, Deepa Rangachari +5 more

A Comprehensive Mutational and Histopathological Analysis of STK11-Mutant Non–Small Cell Lung Carcinomas

Modern Pathology(2025)10.1016/j.modpat.2025.100938
N/A
0DataRank · unranked
1 citations

Zoe Guan, Hyunwoo Kwon, Deepa Rangachari, Daniel B. Costa, Paul A. VanderLaan +1 more